Clinical TrialsSearch results
Number of results: 871
Recruiting
- FAGOTTO study
- Diabetes Mellitus, Type 2
- Maruyama Shoichi
- 2020-11-27
Recruiting
- Open label, multicenter study of gilteritinib in sequential treatment with MEC (Mitoxantrone/ Etoposide/ Cytarabine) in patients with relapsed or refractory FLT3-mutated Acute Myeloid Leukemia
- relapsed/refratory FLT3-mutated acute myeloid leukemia
- Yamauchi Takahiro
- 2020-11-20
Other
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Acalabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects 75 Years With Previously Untreated Non-GCB DLBCL
- Diffuse Large B-Cell Lymphoma
- Hibi Kazushige
- 2020-11-16
Completed
- Comparison of double-lumen endobronchial tube and a combination of LMA ProSeal and bronchial blocker for video assisted thoracoscopic surgery
- Lung tumor
- Nakanishi Toshiyuki
- 2020-11-13
Recruiting
- Study of the efficacy and safety of gemtuzumab ozogamicin treatment intervention with measurable residual disease as an index for AYA/adult acute myeloid leukemia with t(8;21) and inv(16)
- AML with t(8;21)(q22;q22);RUNX1-RUNX1T1 or inv(16)(p13.1q22)/t(16;16)(p13.1;q22);CBFB-MYH11
- Toshihiro Miyamoto
- 2020-11-13
No Longer Recruiting
- The combination therapy with Eldecalcitol and Ibandronate sodium
- Patients diagnosed with osteopenia among patients with gastric cancer after gastrectomy
- Murakami Hideki
- 2020-11-06
Completed
- Effect of Treatment Device for proprioceptive function in the elderly patients with chronic low back pain
- Chronic low back pain
- Yoshihito Sakai
- 2020-11-02
Recruiting
- Study of efficacy of alpha1AR inhibitors for FBD
- Functional bowel disease
- Tsunaki Sawada
- 2020-11-02
Recruiting
- Nagoya University Pancreatic Tumor Board trial 08
- Locally advanced pancreatic cancer
- Takami Hideki
- 2020-10-22
Other
- A multicenter, single arm, open-label trial of prasugrel monotherapy after PCI with the new-generation thin-strut biodegradable polymer everolimus-eluting SYNERGY stent in consecutive patients with chronic coronary syndrome or non-ST-elevation acute coronary syndromes.
- Acute coronary syndrome
- Muramatsu Takashi
- 2020-10-22